Social network
  • Visit We R Hope page

    We R Hope by Sanofi

  • Fighting dengue ferver

    Fighting dengue ferver

  • Meet Anne-Olivier Bandini: R&D Team Leader, France

  • Isabelle, Type 1 diabetes, France

    Isabelle, Type 1 diabetes, France

    Tools content (print, share, increase/decrease text size):


    Middle area:

    R&D Portfolio

    At the end of October 2015, the R&D pipeline contained 41 pharmaceutical new molecular entities (excluding Life Cycle Management) and vaccine candidates in clinical development of which 13 are in Phase III or have been submitted to the regulatory authorities for approvall.


    © Sanofi 2004-2016 - All rights reserved - Update: October 30, 2015

    • Site complies with W3C WCAG 2.0 (new window, in english)